InsiderTrades

Form 4 for TECX Tectonic Therapeutic, Inc.

Accepted 2024-02-05 00:00:00 ET · period of report 2024-02-01 · accession 0001127602-24-003477 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-02-05 2024-02-05 TECX Ostrowski Erik Pres, CFO, Interim CEO F - Tax $1.20 -13.1K 29.3K -31% -$15.7K
D 2024-02-05 2024-02-01 TECX Ostrowski Erik Pres, CFO, Interim CEO M - OptEx $0.00 +40.1K 42.4K +1,743% $0
D 2024-02-05 2024-02-01 TECX Ostrowski Erik Pres, CFO, Interim CEO M - OptEx $0.00 -40.1K 120.2K -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-05 F D 13,099 $1.20 29,285 D — —
2 Common Common Stock 2024-02-01 M A 40,084 $0.00 42,384 D — —
3 Derivative Restricted Stock Unit 2024-02-01 M D 40,084 $0.00 120,249 D $0.00 · — to 2027-02-01 40,084 Common Stock (F1) The shares subject to the RSU shall vest over 4 years, with 25% vesting annually on each anniversary of the Vesting Commencement Date of February 1, 2023.